Hundreds of therapeutic monoclonal antibodies (mAbs) are currently in development, and
many companies have multiple antibodies in their pipelines. Current methodology used in …

Process development in the biotech industry leads to investments around hundred of
millions of dollars. It is important to mitigate costs without neglecting the quality of process …

The biopharmaceutical industries are continuously faced with the pressure to reduce the
development costs and accelerate development time scales. The traditional approach of …

While high‐throughput (HT) experimentation and mechanistic modeling have long been
employed in chromatographic process development, it remains unclear how these …

In recent years, the development of novel recombinant virus‐like particles (VLPs) has been
generating new perspectives for the prevention of untreated and arising infectious diseases …

Bioprocess development today is slow and expensive compared to chemical process
development. A drastic paradigm shift is necessary and possible by the consistent …

Background In industry and academic research, there is an increasing demand for flexible
automated microfermentation platforms with advanced sensing technology. However, up to …

Names: Gottschalk, Uwe, editor. Title: Process scale purification of antibodies/edited by Uwe
Gottschalk. Description: Second edition.| Hoboken, NJ: John Wiley & Sons Inc., 2017 …

The safety requirements for vaccines are extremely high since they are administered to
healthy people. For that reason, vaccine development is time-consuming and very …

Biocatalysis is already established in chemical synthesis on an industrial scale, in particular
in the pharmaceutical sector. However, the wider implementation of biocatalysis is currently …